Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand

Suphak Vanichseni, Dwip Kitayaporn, Timothy D. Mastro, Philip A. Mock, Suwanee Raktham, Don Des Jarlais, Sathit Sujarita, La Ong Srisuwanvilai, Nancy L. Young, Chantapong Wasi, Shambavi Subbarao, William L. Heyward, José Esparza, Kachit Choopanya

Research output: Contribution to journalArticle

Abstract

Background: A large epidemic of HIV-1 subtype B began among injection drug users (IDUs) in Bangkok in 1988. Despite ongoing prevention efforts, HIV-1 prevalence among IDUs remained at 30-50% through the 1990s. Objectives: To measure the incidence of HIV-1 infection and related risk factors to guide prevention efforts and to evaluate the feasibility of conducting an HIV vaccine efficacy trial. Design and methods: A prospective cohort study in which IDUs attending methadone treatment programs in Bangkok were screened during 1995-1996 for enrollment into the study. IDUs found to be HIV-seronegative on two occasions were offered enrollment with follow-up visits every 4 months. On each visit participants were evaluated with a questionnaire and serologic testing. Results: A total of 1209 HIV-negative IDUs were enrolled. Through the end of 1998, the overall HIV-1 incidence rate was 5.8 (95% confidence interval, 4.8-6.8) per 100 person-years of follow-up. HIV-1 subtypes E and B accounted for 79 and 21% of infections, respectively. On multivariate analysis, HIV-1 seroconversion was primarily associated with the frequency of heroin injection, the sharing of injection equipment, and incarceration, especially with drug injection. Sexual behavior was not associated with increased risk for HIV-1. Risk factors for infection with HIV-1 subtypes E and B were similar. Conclusion: HIV-1 transmission risk remains high among Bangkok IDUs despite methadone treatment and other current prevention strategies. There is an urgent need to address this ongoing epidemic, especially in jails and prisons. This study led to the initiation in 1999 of a phase III HIV-1 vaccine efficacy trial in this population.

Original languageEnglish (US)
Pages (from-to)397-405
Number of pages9
JournalAIDS
Volume15
Issue number3
DOIs
StatePublished - Feb 16 2001

Fingerprint

Thailand
Drug Users
HIV-1
Vaccines
Injections
Incidence
AIDS Vaccines
Methadone
HIV
HIV Seropositivity
Prisons
Heroin
Infection
Sexual Behavior
HIV Infections
Cohort Studies
Multivariate Analysis
Prospective Studies
Confidence Intervals
Equipment and Supplies

Keywords

  • Asia
  • HIV-1 incidence
  • HIV-1 subtypes
  • Incarceration
  • Injection drug use
  • Thailand

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Cite this

Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. / Vanichseni, Suphak; Kitayaporn, Dwip; Mastro, Timothy D.; Mock, Philip A.; Raktham, Suwanee; Des Jarlais, Don; Sujarita, Sathit; Srisuwanvilai, La Ong; Young, Nancy L.; Wasi, Chantapong; Subbarao, Shambavi; Heyward, William L.; Esparza, José; Choopanya, Kachit.

In: AIDS, Vol. 15, No. 3, 16.02.2001, p. 397-405.

Research output: Contribution to journalArticle

Vanichseni, S, Kitayaporn, D, Mastro, TD, Mock, PA, Raktham, S, Des Jarlais, D, Sujarita, S, Srisuwanvilai, LO, Young, NL, Wasi, C, Subbarao, S, Heyward, WL, Esparza, J & Choopanya, K 2001, 'Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand', AIDS, vol. 15, no. 3, pp. 397-405. https://doi.org/10.1097/00002030-200102160-00013
Vanichseni, Suphak ; Kitayaporn, Dwip ; Mastro, Timothy D. ; Mock, Philip A. ; Raktham, Suwanee ; Des Jarlais, Don ; Sujarita, Sathit ; Srisuwanvilai, La Ong ; Young, Nancy L. ; Wasi, Chantapong ; Subbarao, Shambavi ; Heyward, William L. ; Esparza, José ; Choopanya, Kachit. / Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. In: AIDS. 2001 ; Vol. 15, No. 3. pp. 397-405.
@article{2dc9be2d63aa487fa7965058650f4a66,
title = "Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand",
abstract = "Background: A large epidemic of HIV-1 subtype B began among injection drug users (IDUs) in Bangkok in 1988. Despite ongoing prevention efforts, HIV-1 prevalence among IDUs remained at 30-50{\%} through the 1990s. Objectives: To measure the incidence of HIV-1 infection and related risk factors to guide prevention efforts and to evaluate the feasibility of conducting an HIV vaccine efficacy trial. Design and methods: A prospective cohort study in which IDUs attending methadone treatment programs in Bangkok were screened during 1995-1996 for enrollment into the study. IDUs found to be HIV-seronegative on two occasions were offered enrollment with follow-up visits every 4 months. On each visit participants were evaluated with a questionnaire and serologic testing. Results: A total of 1209 HIV-negative IDUs were enrolled. Through the end of 1998, the overall HIV-1 incidence rate was 5.8 (95{\%} confidence interval, 4.8-6.8) per 100 person-years of follow-up. HIV-1 subtypes E and B accounted for 79 and 21{\%} of infections, respectively. On multivariate analysis, HIV-1 seroconversion was primarily associated with the frequency of heroin injection, the sharing of injection equipment, and incarceration, especially with drug injection. Sexual behavior was not associated with increased risk for HIV-1. Risk factors for infection with HIV-1 subtypes E and B were similar. Conclusion: HIV-1 transmission risk remains high among Bangkok IDUs despite methadone treatment and other current prevention strategies. There is an urgent need to address this ongoing epidemic, especially in jails and prisons. This study led to the initiation in 1999 of a phase III HIV-1 vaccine efficacy trial in this population.",
keywords = "Asia, HIV-1 incidence, HIV-1 subtypes, Incarceration, Injection drug use, Thailand",
author = "Suphak Vanichseni and Dwip Kitayaporn and Mastro, {Timothy D.} and Mock, {Philip A.} and Suwanee Raktham and {Des Jarlais}, Don and Sathit Sujarita and Srisuwanvilai, {La Ong} and Young, {Nancy L.} and Chantapong Wasi and Shambavi Subbarao and Heyward, {William L.} and Jos{\'e} Esparza and Kachit Choopanya",
year = "2001",
month = "2",
day = "16",
doi = "10.1097/00002030-200102160-00013",
language = "English (US)",
volume = "15",
pages = "397--405",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand

AU - Vanichseni, Suphak

AU - Kitayaporn, Dwip

AU - Mastro, Timothy D.

AU - Mock, Philip A.

AU - Raktham, Suwanee

AU - Des Jarlais, Don

AU - Sujarita, Sathit

AU - Srisuwanvilai, La Ong

AU - Young, Nancy L.

AU - Wasi, Chantapong

AU - Subbarao, Shambavi

AU - Heyward, William L.

AU - Esparza, José

AU - Choopanya, Kachit

PY - 2001/2/16

Y1 - 2001/2/16

N2 - Background: A large epidemic of HIV-1 subtype B began among injection drug users (IDUs) in Bangkok in 1988. Despite ongoing prevention efforts, HIV-1 prevalence among IDUs remained at 30-50% through the 1990s. Objectives: To measure the incidence of HIV-1 infection and related risk factors to guide prevention efforts and to evaluate the feasibility of conducting an HIV vaccine efficacy trial. Design and methods: A prospective cohort study in which IDUs attending methadone treatment programs in Bangkok were screened during 1995-1996 for enrollment into the study. IDUs found to be HIV-seronegative on two occasions were offered enrollment with follow-up visits every 4 months. On each visit participants were evaluated with a questionnaire and serologic testing. Results: A total of 1209 HIV-negative IDUs were enrolled. Through the end of 1998, the overall HIV-1 incidence rate was 5.8 (95% confidence interval, 4.8-6.8) per 100 person-years of follow-up. HIV-1 subtypes E and B accounted for 79 and 21% of infections, respectively. On multivariate analysis, HIV-1 seroconversion was primarily associated with the frequency of heroin injection, the sharing of injection equipment, and incarceration, especially with drug injection. Sexual behavior was not associated with increased risk for HIV-1. Risk factors for infection with HIV-1 subtypes E and B were similar. Conclusion: HIV-1 transmission risk remains high among Bangkok IDUs despite methadone treatment and other current prevention strategies. There is an urgent need to address this ongoing epidemic, especially in jails and prisons. This study led to the initiation in 1999 of a phase III HIV-1 vaccine efficacy trial in this population.

AB - Background: A large epidemic of HIV-1 subtype B began among injection drug users (IDUs) in Bangkok in 1988. Despite ongoing prevention efforts, HIV-1 prevalence among IDUs remained at 30-50% through the 1990s. Objectives: To measure the incidence of HIV-1 infection and related risk factors to guide prevention efforts and to evaluate the feasibility of conducting an HIV vaccine efficacy trial. Design and methods: A prospective cohort study in which IDUs attending methadone treatment programs in Bangkok were screened during 1995-1996 for enrollment into the study. IDUs found to be HIV-seronegative on two occasions were offered enrollment with follow-up visits every 4 months. On each visit participants were evaluated with a questionnaire and serologic testing. Results: A total of 1209 HIV-negative IDUs were enrolled. Through the end of 1998, the overall HIV-1 incidence rate was 5.8 (95% confidence interval, 4.8-6.8) per 100 person-years of follow-up. HIV-1 subtypes E and B accounted for 79 and 21% of infections, respectively. On multivariate analysis, HIV-1 seroconversion was primarily associated with the frequency of heroin injection, the sharing of injection equipment, and incarceration, especially with drug injection. Sexual behavior was not associated with increased risk for HIV-1. Risk factors for infection with HIV-1 subtypes E and B were similar. Conclusion: HIV-1 transmission risk remains high among Bangkok IDUs despite methadone treatment and other current prevention strategies. There is an urgent need to address this ongoing epidemic, especially in jails and prisons. This study led to the initiation in 1999 of a phase III HIV-1 vaccine efficacy trial in this population.

KW - Asia

KW - HIV-1 incidence

KW - HIV-1 subtypes

KW - Incarceration

KW - Injection drug use

KW - Thailand

UR - http://www.scopus.com/inward/record.url?scp=0035895629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035895629&partnerID=8YFLogxK

U2 - 10.1097/00002030-200102160-00013

DO - 10.1097/00002030-200102160-00013

M3 - Article

C2 - 11273220

AN - SCOPUS:0035895629

VL - 15

SP - 397

EP - 405

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 3

ER -